Lv1
40 积分 2023-12-12 加入
LB0005 ORELABRUTINIB, AN IRREVERSIBLE INHIBITOR OF BRUTON'S TYROSINE KINASE (BTK), FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE IB/IIA DOSE-FINDING STUDY
15小时前
求助中
Deep generative models design mRNA sequences with enhanced translational capacity and stability
19天前
已完结
皖公网安备34019202002308
